VOLTRON THERAPEUTICS
Voltron Therapeutics is a Delaware corporation that specializes in cell-mediated responses. It develops precision-guided, self-assembling vaccines for cancer and infectious diseases.
VOLTRON THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.voltrontx.com
Total Employee:
1+
Status:
Active
Contact:
+1646-335-5923
Total Funding:
5.88 M USD
Technology used in webpage:
Euro InMotion Hosting
Similar Organizations
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Current Advisors List
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Voltron Therapeutics
Official Site Inspections
http://www.voltrontx.com Semrush global rank: 6.59 M Semrush visits lastest month: 1.05 K
- Host name: 173.231.198.220
- IP address: 173.231.198.220
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
More informations about "Voltron Therapeutics"
Voltron Therapeutics
Voltron Therapeutics, Inc. is improving cell mediated responses to combat infectious diseases, such as COVID-19 and specific forms of cancers, using the advanced and proprietary …See details»
Management Team - Voltron Therapeutics
Dr. Zachary Shriver has joined the team to provide expertise in protein design, development and manufacturing; globally recognized expert in protein manufacturing.See details»
Voltron Therapeutics, Inc.
VOLTRON is a pre-clinical biotech company focused on bringing our Self-Assembling Vaccines (SAV) to patients with certain cancers or infectious diseases. Infectious pathogens, such as …See details»
Voltron Therapeutics - Overview, News & Similar companies
Nov 19, 2023 · View Voltron Therapeutics (www.voltrontx.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Voltron Therapeutics - Craft
Jun 23, 2022 · It develops VaxCelerate self-assembling vaccine platform that helps to treat infectious diseases, such as COVID-19 and specific forms of cancers. See insights on Voltron …See details»
Voltron Therapeutics, Inc. Executes Manufacturing Agreement
NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced that it has executed a manufacturing agreement for its vaccine portfolio with a global …See details»
Voltron Therapeutics - VentureRadar
Website: https://voltrontx.com/ Voltron Therapeutics, Inc. is improving cell mediated responses to combat infectious diseases, such as COVID-19 and specific forms of cancers, using the …See details»
Pipeline - Voltron Therapeutics
Voltron Therapeutics, Inc., a Delaware corporation, was founded in 2017 to lead and accelerate the development of the Vaccine and Immunotherapy Center (VIC), and the Massachusetts …See details»
Voltron Therapeutics Publishes Letter to Shareholders
May 19, 2020 · Voltron Therapeutics, Inc., a Delaware corporation, was founded in 2017 to lead and accelerate the development of the Vaccine and Immunotherapy Center (VIC), and the …See details»
Voltron Therapeutics Publishes Letter to Shareholders - PR Newswire
May 19, 2020 · Voltron Therapeutics, Inc., a Delaware corporation, was founded in 2017 to lead and accelerate the development of the Vaccine and Immunotherapy Center (VIC), and the …See details»
Patrick Gallagher, CFA - Voltron Therapeutics
He has 20 years of healthcare experience on Wall Street including alternative investments, research and marketing in both the public and private markets.See details»
Voltron Therapeutics Publishes Letter to Shareholders
May 19, 2020 · Voltron Therapeutics, Inc. announces today a letter to the shareholders. Dear Voltron Therapeutics shareholders, We hope this letter finds you well during this remarkable …See details»
Voltron Therapeutics, Inc.’s Post - LinkedIn
Voltron's modular approach signifies a groundbreaking shift in responding to infectious diseases. Their innovative CMC-driven method targets creating new vaccines within 120 days, …See details»
Voltron Therapeutics, Inc. Executes Manufacturing Agreement
NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced that it has executed a manufacturing agreement for its vaccine portfolio with a global …See details»
Voltron Therapeutics, Inc. on LinkedIn: Voltron Therapeutics is ...
Learn more here: https://lnkd.in/gpQ-S9Mg Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Data Demonstrating VaxCelerate Vaccine-Induced Protection Against …See details»
Working at Voltron Data - Glassdoor
Voltron Data offers a new way to design and build composable data systems. Founded in 2021, the global team is led by data engineers and core open-source maintainers driving innovation …See details»
Voltron Therapeutics Publishes Letter to Shareholders
May 19, 2020 · Voltron Therapeutics, Inc., a Delaware corporation, was founded in 2017 to lead and accelerate the development of the Vaccine and Immunotherapy Center (VIC), and the …See details»
Voltron Therapeutics, Inc. Executes Manufacturing Agreement with …
NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced that it has executed a manufacturing agreement for its vaccine portfolio with a global …See details»
News - Voltron Therapeutics
Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD Award will advance the Self-Assembling Vaccine Platform for rapid …See details»